Startup Spotlight: UNC-linked startup is giving hope to those with hemophilia

February 8, 2022

GeneVentiv Therapeutics is developing the first universal gene therapy for all types of hemophilia, including the most difficult cases. By working to bring breakthrough therapies to market, this UNC-affiliated startup is also instilling expanded hope in hemophilia patients who wrestle with the daily realities of their life threatening, inherited disorder.

Categories: GeneVentiv Therapeutics

Durham firm offering up to $10,000 for researchers to use its intestinal technology

October 15, 2021

Durham-based Altis Biosystems is offering a research award of up to $10,000 for a scientific team to use its proprietary drug-development technology in a research project.

Categories: Altis Biosystems

UNC-Chapel Hill Once Again Tops $1 Billion in Research Awards

August 11, 2021

For the second year in a row, awards for research conducted at the University of North Carolina at Chapel Hill exceeded $1 billion.

Categories: UNC Research

UNC’s vice chancellor for innovation, entrepreneurship is retiring

February 22, 2021

After 11 years of dedicated service and commitment to the University and the state, Judith Cone, vice chancellor for innovation, entrepreneurship and economic development, will retire from Carolina in April.

Categories: Carolina Research Ventures News

Durham-based 410 Medical wins Entrepreneurial Company of Year award

February 9, 2021

Frost & Sullivan, a California company specializing in business growth and development, has named Durham’s 410 Medical, Inc. as the 2021 Entrepreneurial Company of the Year in the global fluid resuscitation devices industry.

Categories: 410 Medical